Group One Trading’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3K | Hold |
1,273
| – | – | ﹤0.01% | 1778 |
|
|
2025
Q1 | $2.58K | Buy |
1,273
+141
| +12% | +$286 | ﹤0.01% | 1647 |
|
|
2024
Q4 | $6.77K | Sell |
1,132
-753
| -40% | -$4.51K | ﹤0.01% | 1597 |
|
|
2024
Q3 | $18.4K | Buy |
+1,885
| New | +$18.4K | ﹤0.01% | 1191 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1926 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1943 |
|
|
2023
Q4 | – | Sell |
-2,409
| Closed | -$97.5K | – | 2069 |
|
|
2023
Q3 | $97.5K | Buy |
+2,409
| New | +$97.5K | ﹤0.01% | 927 |
|
|
2023
Q2 | – | Sell |
-24
| Closed | -$7.28K | – | 1978 |
|
|
2023
Q1 | $7.28K | Sell |
24
-1,864
| -99% | -$565K | ﹤0.01% | 1380 |
|
|
2022
Q4 | $649K | Buy |
+1,888
| New | +$649K | ﹤0.01% | 474 |
|
|
2022
Q3 | – | Sell |
-303
| Closed | -$64K | – | 2115 |
|
|
2022
Q2 | $64K | Sell |
303
-309
| -50% | -$65.3K | ﹤0.01% | 1207 |
|
|
2022
Q1 | $205K | Buy |
612
+352
| +135% | +$118K | ﹤0.01% | 1024 |
|
|
2021
Q4 | $85K | Sell |
260
-486
| -65% | -$159K | ﹤0.01% | 1439 |
|
|
2021
Q3 | $362K | Sell |
746
-103
| -12% | -$50K | ﹤0.01% | 933 |
|
|
2021
Q2 | $395K | Sell |
849
-268
| -24% | -$125K | ﹤0.01% | 888 |
|
|
2021
Q1 | $772K | Sell |
1,117
-82
| -7% | -$56.7K | ﹤0.01% | 615 |
|
|
2020
Q4 | $886K | Sell |
1,199
-629
| -34% | -$465K | ﹤0.01% | 492 |
|
|
2020
Q3 | $1.27M | Buy |
1,828
+293
| +19% | +$203K | ﹤0.01% | 320 |
|
|
2020
Q2 | $1.3M | Sell |
1,535
-714
| -32% | -$606K | 0.01% | 251 |
|
|
2020
Q1 | $804K | Buy |
+2,249
| New | +$804K | 0.01% | 274 |
|